Inovio Pharmaceuticals Inc (INO)

[Lakers_w]

Tuesday 30th November
Track EMERGING APPROACHES TO ANTIVIRALS
2:25 PST DNA encoded monoclonal antibody treatment for infectious disease and beyond
Dr Laurent Humeau, CSO–EVP of R&D, Engineering and Clinical Developments, Inovio

The Vaccine & Immunotherapy Congress West Coast is returning to reunite the community in real life (yes, in-person!) - on 30 November - 2 December in San Diego!

This is the West Coast edition of our most recognised World Vaccine Congress series, and it will attract hundreds of vaccine & immunotherapy leaders.
https://www.terrapinn.com/conference/world-vaccine-immunotherapy-congress-west-coast/speakers.stm?utm_source=pardot&utm_medium=email&utm_campaign=email&utm_term=email
https://www.terrapinn.com/template/Live/PDF/Vaccine--Immunotherapy-Congress-West-Co/10488/21818/bmV3LXd2aWMtLXd

3rd GBM Drug Development Summit. Conference Day Two
Thursday, January 20, 2022
A Deep Dive into DNA Damage Repair for GBM
Jeffrey Skolnik
VP Clinical Development Inovio
8:40A EST
Inovio’s DNA Medicine for the Treatment of Glioblastoma:
• UsingnovelDNA-encodedmedicinestotreathumancancerssuchasGBM
• Generating robust, specific anti-tumor T cells against GBM antigens
• Combining DNA medicine with immune checkpoint inhibitors to build clinical responses
January 18 - 20, 2022 | Boston MA
https://glioblastoma-drugdevelopment.com/